Outcome reporting across randomised controlled trials evaluating therapeutic interventions for pre‐eclampsia

Standardising outcome collection and reporting in pre‐eclampsia trials requires an appraisal of current outcome reporting.

[1]  S. Ziebland,et al.  Core outcome sets in women's and newborn health: a systematic review , 2017, BJOG : an international journal of obstetrics and gynaecology.

[2]  J. Wilkinson,et al.  Reducing research waste in benign gynaecology and fertility research , 2017, BJOG : an international journal of obstetrics and gynaecology.

[3]  J. Langenveld,et al.  An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT‐II) , 2017, BJOG : an international journal of obstetrics and gynaecology.

[4]  D. Grossman,et al.  Standardizing abortion research outcomes (STAR): a protocol for developing, disseminating and implementing a core outcome set for medical and surgical abortion☆ , 2017, Contraception.

[5]  K. Khan,et al.  Protocol for developing, disseminating and implementing a core outcome set for endometriosis , 2016, BMJ Open.

[6]  S. Ziebland,et al.  A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia. , 2016, Pregnancy hypertension.

[7]  J. Duffy,et al.  Influence of methodology upon the identification of potential core outcomes: recommendations for core outcome set developers are needed , 2016, BJOG : an international journal of obstetrics and gynaecology.

[8]  H. Wunsch,et al.  Reporting data on long-term follow-up of critical care trials , 2016, Thorax.

[9]  M. Plana,et al.  Variation in outcome reporting in endometriosis trials: a systematic review. , 2016, American journal of obstetrics and gynecology.

[10]  G. Saade,et al.  A Core Outcome Set for Evaluation of Interventions to Prevent Preterm Birth , 2016, Obstetrics and gynecology.

[11]  J. Zamora,et al.  Variation in the reporting of outcomes among pregnant women with epilepsy: a systematic review. , 2015, European journal of obstetrics, gynecology, and reproductive biology.

[12]  B. Mol,et al.  Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial , 2015, The Lancet.

[13]  D. Altman,et al.  Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews , 2014, BMJ : British Medical Journal.

[14]  K. Khan.  The CROWN Initiative: journal editors invite researchers to develop core outcomes in women's health , 2014, Journal of Family Planning and Reproductive Health Care.

[15]  L. Katz,et al.  Abbreviated (12‐hour) versus traditional (24‐hour) postpartum magnesium sulfate therapy in severe pre‐eclampsia , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[16]  K. Khan,et al.  Variations in the reporting of outcomes used in systematic reviews of treatment effectiveness research in bladder pain syndrome. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[17]  K. Khan.  The CROWN Initiative: journal editors invite researchers to develop core outcomes in women's health , 2014, BJOG : an international journal of obstetrics and gynaecology.

[18]  K. Khan.  The CROWN Initiative: journal editors invite researchers to develop core outcomes in women's health. , 2014, Contraception.

[19]  M. Owens,et al.  Management of preeclampsia when diagnosed between 34-37 weeks gestation: deliver now or deliberate until 37 weeks? , 2014, Journal of the Mississippi State Medical Association.

[20]  L. Magee,et al.  The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. , 2014, Pregnancy hypertension.

[21]  R. Tibshirani,et al.  Increasing value and reducing waste in research design, conduct, and analysis , 2014, The Lancet.

[22]  U. Dirnagl,et al.  Biomedical research: increasing value, reducing waste , 2014, The Lancet.

[23]  J. Ludmir,et al.  Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial. , 2013, American journal of obstetrics and gynecology.

[24]  R. Barakat,et al.  Does immediate postpartum curettage of the endometrium accelerate recovery from preeclampsia–eclampsia? A randomized controlled trial , 2013, Archives of Gynecology and Obstetrics.

[25]  S. Manotaya,et al.  Magnesium sulfate maintenance infusion in women with preeclampsia: a randomized comparison between 2 gram per hour and 1 gram per hour. , 2013, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[26]  Jane M Blazeby,et al.  Developing core outcome sets for clinical trials: issues to consider , 2012, Trials.

[27]  S. Dasgupta,et al.  Randomized controlled study comparing effect of magnesium sulfate with placebo on fetal umbilical artery and middle cerebral artery blood flow in mild preeclampsia at ≥34 weeks gestational age , 2012, The journal of obstetrics and gynaecology research.

[28]  A. Regi,et al.  A shortened postpartum magnesium sulfate prophylaxis regime in pre‐eclamptic women at low risk of eclampsia , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[29]  P. Williamson,et al.  Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies , 2011, PLoS medicine.

[30]  A. Shennan,et al.  An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre‐eclampsia at term (HYPITAT trial) , 2010, BJOG : an international journal of obstetrics and gynaecology.

[31]  J. A. Johnston,et al.  Digoxin Immune Fab Treatment for Severe Preeclampsia , 2010, American journal of perinatology.

[32]  Douglas G Altman,et al.  The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews , 2010, BMJ : British Medical Journal.

[33]  G. Mires,et al.  A Randomised, Double-Blinded, Placebo-Controlled Study of the Phosphodiesterase Type 5 Inhibitor Sildenafil for the Treatment of Preeclampsia , 2009, Hypertension in pregnancy.

[34]  A. Franx,et al.  Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial , 2009, The Lancet.

[35]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[36]  A. Hoffman,et al.  Antepartum continuous epidural ropivacaine therapy reduces uterine artery vascular resistance in pre-eclampsia: a randomized, dose-ranging, placebo-controlled study. , 2009, British journal of anaesthesia.

[37]  V. Buckalew,et al.  The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial , 2009, Journal of Perinatology.

[38]  J. F. Hernández-Sierra,et al.  EFFICACY OF NITROGLYCERINE INFUSION VERSUS SUBLINGUAL NIFEDIPINE IN SEVERE PRE‐ECLAMPSIA: A RANDOMIZED, TRIPLE‐BLIND, CONTROLLED TRIAL , 2008, Clinical and experimental pharmacology & physiology.

[39]  G. Saade,et al.  L-Arginine Supplementation in Patients with Gestational Hypertension: A Pilot Study , 2007, Hypertension in pregnancy.

[40]  L. Doyle,et al.  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years , 2006, BJOG : an international journal of obstetrics and gynaecology.

[41]  D. Altman,et al.  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months , 2006, BJOG : an international journal of obstetrics and gynaecology.

[42]  B. Mercer,et al.  Abbreviated Postpartum Magnesium Sulfate Therapy for Women With Mild Preeclampsia: A Randomized Controlled Trial , 2006, Obstetrics and gynecology.

[43]  R. Olszanecki,et al.  Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report. , 2006, Basic & clinical pharmacology & toxicology.

[44]  H. Hopp,et al.  Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[45]  J. López,et al.  Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[46]  E. Steegers,et al.  Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[47]  M. Druzin,et al.  Effect of l-Arginine Therapy on the Glomerular Injury of Preeclampsia: A Randomized Controlled Trial , 2006, Obstetrics and gynecology.

[48]  Lelia Duley,et al.  Cost‐effectiveness of prophylactic magnesium sulphate for 9996 women with pre‐eclampsia from 33 countries: economic evaluation of the Magpie Trial , 2006, BJOG : an international journal of obstetrics and gynaecology.

[49]  W. Fetter,et al.  A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre‐eclampsia , 2005, BJOG : an international journal of obstetrics and gynaecology.

[50]  L. Groome,et al.  A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy. , 2005, American journal of obstetrics and gynecology.

[51]  J. Martin,et al.  Postpartum Preeclampsia Management With Furosemide: A Randomized Clinical Trial , 2005, Obstetrics and gynecology.

[52]  T. Henriksen,et al.  Dietary supplementation with l‐arginine or placebo in women with pre‐eclampsia , 2004, Acta obstetricia et gynecologica Scandinavica.

[53]  T. Terao,et al.  Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study. , 2003, Seminars in thrombosis and hemostasis.

[54]  B. Sibai,et al.  Magnesium Sulfate in Women With Mild Preeclampsia: A Randomized Controlled Trial , 2003, Obstetrics and gynecology.

[55]  G. Saade,et al.  A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. , 2003, The New England journal of medicine.

[56]  F. Abroug,et al.  Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol , 2002, Intensive Care Medicine.

[57]  D. Altman,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[58]  H. Odendaal,et al.  The optimal dosage of ketanserin for patients with severe hypertension in pregnancy. , 2002, European Journal of Obstetrics, Gynecology, and Reproductive Biology.

[59]  H. Sahin,et al.  Induction of labor in toxemia with misoprostol , 2002, Acta Obstetricia et Gynecologica Scandinavica.

[60]  I. Adam,et al.  Methyldopa versus no drug treatment in the management of mild pre-eclampsia. , 2002, East African medical journal.

[61]  B. S. Aali,et al.  Nifedipine or hydralazine as a first‐line agent to control hypertension in severe preeclampsia , 2002, Acta obstetricia et gynecologica Scandinavica.

[62]  C. Connolly,et al.  COMPARISON OF THE EFFICACY OF CONTINUOUS FUROSEMIDE AND LOW-DOSE DOPAMINE INFUSION IN PREECLAMPSIA/ECLAMPSIA-RELATED OLIGURIA IN THE IMMEDIATE POSTPARTUM PERIOD , 2002, Hypertension in pregnancy.

[63]  T. Terao,et al.  Antithrombin Therapy for Severe Preeclampsia , 2000, Thrombosis and Haemostasis.

[64]  E. Martínez-Abundis,et al.  Sublingual Isosorbide Dinitrate in the Acute Control of Hypertension in Patients with Severe Preeclampsia , 2000, Gynecologic and Obstetric Investigation.

[65]  H. Odendaal,et al.  Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial , 2000, BJOG : an international journal of obstetrics and gynaecology.

[66]  R. Newman,et al.  A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies. , 1999, American journal of obstetrics and gynecology.

[67]  A. Faúndes,et al.  Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. , 1999, American journal of obstetrics and gynecology.

[68]  H. V. van Geijn,et al.  Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome. , 1999, American journal of obstetrics and gynecology.

[69]  J. D. Stewart,et al.  Pre-eclampsia and induction of labor: a randomized comparison of prostaglandin E2 as an intracervical gel, with oxytocin immediately, or as a sustained-release vaginal insert. , 1998, American journal of obstetrics and gynecology.

[70]  J. Makin,et al.  Low dose dopamine in postpartum pre‐eclamptic women with oliguria: a double‐blind, placebo controlled, randomised trial , 1997, British journal of obstetrics and gynaecology.

[71]  J. Stark,et al.  Antioxidants in the treatment of severe pre‐eclampsia: an explanatory randomised controlled trial , 1997, British journal of obstetrics and gynaecology.

[72]  G. Hofmeyr,et al.  Antioxidants in the treatment of severe pre‐eclampsis an explanatory randomised controlled trial , 1997, British journal of obstetrics and gynaecology.

[73]  A. Witlin,et al.  The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial. , 1997, American journal of obstetrics and gynecology.

[74]  T. Tongsong,et al.  A comparison of serum magnesium sulfate levels in pregnant women with severe preeclampsia between intravenous and intramuscular magnesium sulfate regimens: a randomized controlled trial. , 1996, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[75]  R. Collins,et al.  Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy , 1995 .

[76]  J. Hauth,et al.  Does magnesium sulfate affect the length of labor induction in women with pregnancy-associated hypertension? , 1995, American journal of obstetrics and gynecology.

[77]  K. Maršál,et al.  Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. , 1995, American journal of obstetrics and gynecology.

[78]  K. Leveno,et al.  A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. , 1995, The New England journal of medicine.

[79]  R. Collins,et al.  WHICH ANTICONVULSANT FOR WOMEN WITH ECLAMPSIA - EVIDENCE FROM THE COLLABORATIVE ECLAMPSIA TRIAL , 1995 .

[80]  The Surfaxin-Lavage for Mas Trial Group.  Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial , 1995, The Lancet.

[81]  C. Adair,et al.  Calcium Supplementation in Mild Preeclampsia Remote From Term: A Randomized Double‐Blind Clinical Trial , 1995, Obstetrics and gynecology.

[82]  H. Odendaal,et al.  Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial. , 1995, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[83]  M. Hashem,et al.  Labetalol vs. methyldopa in the treatment of pregnancy‐induced hypertension , 1995, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[84]  Shuenn-Dyh Chang,et al.  Expectant management in severe preeclampsia: does magnesium sulfate prevent the development of eclampsia? , 1995, Acta obstetricia et gynecologica Scandinavica.

[85]  J. Moodley,et al.  Intravenous and intramuscular magnesium sulphate regimens in severe pre-eclampsia. , 1994, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[86]  B. Sibai,et al.  Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. , 1994, American journal of obstetrics and gynecology.

[87]  B. Carbonne,et al.  Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: A randomized comparative trial , 1994, Obstetrics and gynecology.

[88]  Jeffrey R. Wilson,et al.  CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women , 1994, The Lancet.

[89]  P. Belfrage,et al.  Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants , 1993, Acta obstetricia et gynecologica Scandinavica.

[90]  O. Hovatta,et al.  Dietary supplementation with primrose oil or fish oil does not change urinary excretion of prostacyclin and thromboxane metabolites in pre-eclamptic women. , 1993, Prostaglandins, leukotrienes, and essential fatty acids.

[91]  S. Akl,et al.  A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term , 1993, American journal of obstetrics and gynecology.

[92]  K. Lim,et al.  Phenytoin Versus Magnesium Sulfate in Preeclampsia: A Pilot Study , 1993, American journal of perinatology.

[93]  M. Belfort,et al.  Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: A randomized, placebo‐controlled study , 1993, American journal of obstetrics and gynecology.

[94]  Rick W. Martin,et al.  Immediate Postpartum Curettage: Accelerated Recovery From Severe Preeclampsia , 1993, Obstetrics and gynecology.

[95]  W. Rj,et al.  [Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents]. , 1993, Ginecologia y obstetricia de Mexico.

[96]  A. Ismail,et al.  Evaluation of calcium‐antagonist (Nifedipine) in the treatment of pre‐eclampsia , 1993, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[97]  G. Saade,et al.  The effect of magnesium sulfate on maternal retinal blood flow in preeclampsia: a randomized placebo-controlled study. , 1992, American journal of obstetrics and gynecology.

[98]  I. Meizner,et al.  Flow velocity analysis of umbilical and uterine artery flow in pre‐eclampsia treated with propranolol or pindolol , 1992, Journal of clinical ultrasound : JCU.

[99]  D. Grové,et al.  Aggressive or Expectant Management for Patients With Severe Preeclampsia Between 28–34 Weeks' Gestation: A Randomized Controlled Trial , 1990, Obstetrics and gynecology.

[100]  J. Barton,et al.  The use of nifedipine during the postpartum period in patients with severe preeclampsia. , 1990, American journal of obstetrics and gynecology.

[101]  R. Norman,et al.  Attempts at dietary alteration of prostaglandin pathways in the management of pre-eclampsia. , 1989, Prostaglandins, leukotrienes, and essential fatty acids.

[102]  B. Sibai,et al.  A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term , 1987, Obstetrics and gynecology.

[103]  E. Amon,et al.  A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy , 1987, Obstetrics and gynecology.

[104]  S. Ziebland,et al.  Developing a pre-eclampsia core outcome set. Round 1 results: 283 healthcare professionals, 41 researchers and 112 patients from 55 countries participated , 2017 .

[105]  Published Online.  Biomedical research: increasing value, reducing waste , 2014 .

[106]  R. Verma,et al.  A COMPARATIVE RANDOMISED CONTROLLED PARALLEL GROUP STUDY OF EFFICACY AND TOLERABILITY OF LABETALOL VERSUS METHYLDOPA IN THE TREATMENT OF NEW ONSET HYPERTENSION DURING PREGNANCY , 2012 .

[107]  Ritu S. Sharma,et al.  Efficacy of Magnesium Sulphate Versus Phenytoin in Seizure Control and Prophylaxsis in Patients of Eclampsia and Severe Pre-eclampsia , 2008 .

[108]  I. Marcovici.  Postpartum preeclampsia management with furosemide: a randomized clinical trial. , 2005, Obstetrics and gynecology.

[109]  R. Gornall,et al.  A randomised placebo controlled trial of loop diuretics in moderate/severe pre-eclampsia, following delivery. , 1997, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[110]  M. Toppozada,et al.  Management of severe pre-eclampsia with prostaglandin A, a useful therapeutic approach , 1989 .

[111]  G. Rydén,et al.  Metoprolol in the Treatment DF Mild to Moderate Hypertension in Pregnancy-Effects on the Mother , 1985 .